Pandiyan’s Musings — Reflections on Health, Life & Learning

Pandiyan Natarajan
  • 5.0 (3)
  • Medicine

This is is not medical advice. This is food for thought. Please discuss with your doctor before making any change in your food and lifestyle. The escalating global incidence of Type 2 Diabetes Mellitus (T2DM) over the past five decades directly correlates with the parallel rise in overweight and obesity, forming an intertwined epidemic termed "diabesity." This podcast argues that the primary driver of this crisis is the pervasive consumption of "inappropriate food," particularly refined carbohydrates and ultra-processed foods, which disrupt metabolic homeostasis and promote weight gain. We propose that "appropriate food"—defined as whole, fresh, local, plant-based, minimally processed, or unprocessed foods, consumed in appropriate amounts and at appropriate times, and complemented by age-specific exercise—constitutes the fundamental and most effective intervention for T2DM prevention, management, and even remission. This lifestyle-centric approach, supported by emerging insights into the gut microbiome and personalized monitoring via continuous glucose monitors, often renders long-term pharmacotherapy unnecessary and potentially harmful. We critically examine the conventional reliance on chronic drug therapy, highlighting its significant side effects and questionable long-term morbidity/mortality benefits, advocating instead for its judicious use primarily in acute medical emergencies. This podcast calls for a paradigm shift in T2DM management, prioritizing sustainable, food-based lifestyle interventions over a drug-centric model. Disclaimer: This is an opinion podcast for educational purposes only and does not constitute medical advice. Listeners should consult their healthcare providers before making any decisions about diagnosis or treatment.

  1. 2d ago

    Our Microbial Menagerie

    Our Microbial Menagerie For centuries, medicine quite rightly taught us to fear microbes. Pasteur and Koch transformed our understanding of infection, while antibiotics, sanitation and vaccination saved countless lives. But perhaps this success left us with a lasting reflex: microbe = enemy. The microbial world tells a much bigger story. Microbes are among the great ecological engineers of our planet. They recycle the dead, drive the carbon and nitrogen cycles, support plant life and participate in processes as remarkable as the formation of atmospheric ice that can contribute to rainfall. And microbes are intimately woven into us. The familiar claim that bacteria outnumber human cells ten to one was revised in 2016. Estimates suggested roughly 38 trillion bacterial cells alongside about 30 trillion human cells in a reference adult—a relationship much closer to one-to-one. (PLOS) The numbers, however, are less important. Our largest microbial community lives in the gut. These organisms help digest components of food that we cannot digest ourselves and produce metabolites such as short-chain fatty acids that influence intestinal, metabolic and immune function. Microbial products also participate in a complex conversation between the gut and the brain. The reproductive tract provides another fascinating example. The vaginal microbiota is often dominated by Lactobacillus, which can help maintain an acidic environment and contribute to colonisation resistance. Yet microbial communities vary between individuals and change with circumstances. We did not simply acquire these organisms. We evolved with them. Human milk contains oligosaccharides that the infant cannot digest efficiently. These compounds help nourish particular bacteria, especially bifidobacteria. Breast milk therefore feeds the developing microbial community as well as the baby.. Antibiotics are among medicine’s greatest triumphs. My concern is their indiscriminate use. Broad-spectrum antibiotics can disrupt microbial communities. Recurrent Clostridioides difficile infection offers one of the clearest clinical demonstrations that disruption of the intestinal ecosystem can contribute to disease—and that restoration of the microbial community can sometimes be therapeutic.. For conditions such as obesity, inflammatory bowel disease and autoimmune disorders, associations between microbiome changes and disease remain complex. Association is not proof of causation. Medicine should resist microbiome hype just as firmly as it resisted the old idea that all microbes are enemies. The answer is not to abandon hygiene. Clean water, sanitation, handwashing and vaccination remain fundamental to public health. Perhaps the lesson is more subtle: cleanliness is not the same as sterility. Use antibiotics when they are truly needed. Eat a varied, fibre-rich diet that can nourish microbial communities. Spend time in natural environments. And recognise that we live in intimate ecological partnership with organisms we once regarded almost exclusively as adversaries. Thiruvalluvar wrote: பகுத்துண்டு பல்லுயிர் ஓம்புதல் நூலோர் தொகுத்தவற்றுள் எல்லாம் தலை. To share one’s food and protect all living beings is foremost among the virtues described by the wise.. Yet the principle feels remarkably contemporary. Perhaps the next chapter of medicine is learning not merely how to kill microbes, but which ones to protect, which ones to restore, and which ones to leave alone. We are, after all, hosts. It is time we behaved like good ones.

    Our Microbial Menagerie

  2. Sep 26

    Is Love the Best Medicine? Charity begins at home, and so does loving

    Is Love the Best Medicine? After fifty years of practising medicine, I keep returning to a simple question: can love be considered a medicine? Not a substitute for medicine, certainly. A tablet may treat disease, a procedure may correct a disorder, a hormone may replace what is deficient, and an operation may remove what is harmful. But perhaps medicine itself works best when it is delivered with love. It begins with self-love—not narcissism, but self-respect. When we value ourselves, we have a reason to care for our health. Self-love does not make us perfect, but it can help us protect what we value. From the self, the circle of love can widen. It may begin with family, then include friends and neighbours, community, language and country. A child begins with a small circle; as the child grows, it should grow too. The ancient Tamil poet Kaniyan Poongundranar captured the ultimate expansion of that circle: “யாதும் ஊரே யாவரும் கேளிர்” Every place is my own; every person is my kin. The Sanskrit tradition expresses a similar ideal through Vasudhaiva Kutumbakam—the world is one family. Both traditions point to the same destination: love should keep expanding until there is no “other”. True love is therefore universal. Loving one person while deliberately hating another is not the highest expression of love. Love may not magically eliminate anger or disagreement, but it can prevent hatred from becoming the governing force. The same principle applies to work. When we love what we do, effort can become something we willingly give. Love can stimulate curiosity, learning, dedication and resilience. It does not prevent exhaustion or guarantee freedom from burnout, but meaningful work can provide resilience. And love needs no translation. At the bedside, a frightened patient may understand a gentle hand before understanding a single word. A smile, a reassuring touch, patience, a listening ear and simply being present can communicate something that language sometimes cannot. Yet true love is not blind. Sometimes love requires intervention. Sometimes it requires saying “no”. Sometimes it means allowing someone to fall, learn and grow. A child needs both roots and wings—the security of knowing there is a place to return to and the freedom to discover the world independently. This brings me back to medicine. My fifty years of observation have taught me that patients respond not only to what we do, but also to how we do it. Illness can feel profoundly different when a patient feels heard, respected, reassured and cared for. Research on social connection, social support and patient–clinician relationships provides a scientific framework for some of these observations. Human connection can influence wellbeing, health behaviours, treatment engagement and recovery. But love itself is difficult to measure as a clinical intervention. It cannot be prescribed at a particular dose or dispensed from a pharmacy. Perhaps that is why it matters. Love is not a substitute for medicine. But perhaps medicine itself works best when it is delivered with love. After fifty years, this is one prescription I have become increasingly convinced about: Begin with loving yourself. Let that love widen to your family. Let it widen further to your community and country. Then keep widening the circle until it embraces the whole of humanity—and ultimately all living things. Love may not be the only medicine. But it may be the medicine that makes us more human.

    Is Love the Best Medicine? Charity begins at home, and so does loving

  3. Sep 20

    The Vettiyan’s Paradox: Is There Really Such a Thing as Win-Win?

    The Vettiyan’s Paradox: Is There Really Such a Thing as Win-Win? We like to believe that everyone can win. But can they? A Tamil saying attributed to the vettiyan, the man who tends the burning ground, says: செத்ததால் சாகவில்லை, சாகாவிட்டால் செத்து இருப்போம். “Because others died, we did not die; Had they not died, we would have.” The vettiyan does not cause death, nor does he wish for it. Yet his livelihood, and his family’s survival, depend upon people dying. Now imagine medicine succeeding spectacularly. Vaccines spread, infant mortality falls, heart attacks are treated promptly and people live longer. Society wins. Families win. But the vettiyan loses his livelihood. So is there ever a true win-win? Many advances cast a shadow somewhere. The funeral worker’s lost income is visible; the lives saved are less visible. The loss is real, but the wider gain may be far greater. No sensible society would ask a village to keep dying so that its vettiyan can remain employed. Yet when progress destroys a legitimate livelihood, what do we owe the person who loses? Perhaps an opportunity to change. But not all shadows are alike. The vettiyan waits. He has no power to bring death a day closer. His interest in death is passive. Perhaps we should ask: Does the beneficiary’s income rise when suffering rises? And can the beneficiary influence whether that suffering occurs? The vettiyan answers yes to the first and no to the second. Where both answers are yes, society should be particularly vigilant. That does not prove dishonesty; it means incentives deserve scrutiny. Medicine cannot entirely escape this question. Most doctors want their patients well, yet healthcare systems can sometimes reward continuing management more readily than prevention or cure. If incentives reward illness more reliably than health, perhaps the system deserves scrutiny. And the paradox extends far beyond the vettiyan. When two warring nations sign peace, humanity gains—but an arms supplier may lose business. When two people barter apples and oranges directly, both may gain—but the fruit seller who would otherwise have sold them may lose. Even nature makes no promise of universal winners. For the lion to succeed in its hunt, the deer must lose. Win-win is not a universal law of life. It is an arrangement we sometimes manage to create. The same person can be both loser and winner. The vettiyan may lose his livelihood while gaining as a human being in a healthier society. So perhaps the important question is not whether everyone can win every time, but what we owe those who lose when society moves forward. We can help people change their livelihoods, redesign incentives, and remain vigilant when beneficiaries can also influence the persistence of suffering. Thiruvalluvar put the moral principle beautifully: அறிவினான் ஆகுவ துண்டோ பிறிதின்நோய் தந்நோய்போல் போற்றாக் கடை. What is the use of learning if we cannot regard another person’s suffering as our own? We cannot guarantee that everyone will win. But we can decide how we treat those who lose. We like to believe that everyone can win. Nature has never made us such a promise.

    The Vettiyan’s Paradox: Is There Really Such a Thing as Win-Win?

  4. Sep 13

    Supplements, Supplements, Supplements Everywhere — But Is Any of Real Use?

    Supplements, Supplements, Supplements Everywhere — But Do We Really Need Them? Supplements have become almost unavoidable in modern life. Vitamins, minerals, protein powders, antioxidants, omega-3s, probiotics and herbal products are marketed for better health, energy, immunity, fertility and longevity. But one question deserves to be asked before swallowing the next capsule: do we actually need it? After 50 years in medicine and 40 years in andrology and reproductive sciences, I have never routinely prescribed supplements as empirical treatment for infertility. I have generally avoided taking them myself. That personal experience is not scientific evidence, but it has made me interested in the difference between biological plausibility and demonstrated clinical benefit. When there is a genuine deficiency, supplementation is treatment. B12 deficiency requires B12. Iron-deficiency anaemia requires iron. Certain preventive interventions also have a defined evidence base, such as folic acid around conception. But giving a supplement to an otherwise healthy person simply because a nutrient has an attractive biological role is different. A nutrient is not automatically a treatment. Biological plausibility is not clinical efficacy. A mechanism is a reason to conduct a clinical trial—not a reason to take a drug. Male infertility provides a useful example. Antioxidants are widely promoted because oxidative stress is thought to damage sperm. Yet a Cochrane review of 90 randomised trials involving 10,303 subfertile men found only very-low-certainty evidence for increased live birth. When high-risk studies were removed, the apparent benefit disappeared. Current European guidance does not support routine antioxidant treatment for idiopathic infertility. PCOS presents a similar problem. Inositol is widely promoted as a fertility supplement, but the 2023 International Evidence-based PCOS Guideline considers inositol for infertility experimental because evidence for benefits and harms remains too uncertain. Perhaps the most powerful warning comes from prevention trials. In SELECT trial, vitamin E was tested in healthy men because antioxidant biology suggested a possible reduction in prostate cancer. Instead, vitamin E supplementation increased prostate cancer risk by 17%. CARET trial provided another sobering lesson. More than 18,000 high-risk participants received beta-carotene plus vitamin A or placebo. The trial was stopped early because the supplemented group developed 28% more lung cancers and experienced 17% more deaths. The lesson is that the burden of proof should remain where it belongs. If there is a deficiency, treat it. If there is a specific preventive indication, consider it. If the person is otherwise healthy, demand evidence. Before taking a supplement, ask: What problem am I trying to solve?Do I actually have that problem?Is this supplement proven to solve it?Can it cause harm?We should not confuse food with a collection of isolated nutrients. The nutrient is not necessarily the food, and a capsule is not necessarily an improvement on a meal. Thiruvalluvar expressed the principle beautifully in the Thirukkural: மருந்தென வேண்டாவாம் யாக்கைக்கு அருந்தியது அற்றது போற்றி உணின். “The body needs no medicine at all, if one eats—with due care—only after what was eaten before has been digested.” Good food should be the foundation of nutrition, not an excuse for indiscriminate supplementation. A supplement should have to justify its existence—not merely by its marketing, mechanism or popularity, but by its evidence.

    Supplements, Supplements, Supplements Everywhere — But Is Any of Real Use?

  5. Sep 6

    Semaglutide and Its Siblings: Are We Trying to Eat the Cake and Have It Too? Or are we teaching the body to forget hunger while the world that made it hungry stays the same?

    Semaglutide and its siblings—tirzepatide, retatrutide and newer oral formulations—are transforming the treatment of obesity and metabolic disease. Their success is real. But does extraordinary efficacy risk making us ask too few questions? The SELECT trial demonstrated a 20% reduction in major cardiovascular events in people with overweight or obesity, established cardiovascular disease and no diabetes. FLOW demonstrated substantial kidney protection in people with type 2 diabetes and chronic kidney disease. These are important clinical advances. Yet we should be careful about what we infer from them. Do benefits appearing before substantial measured weight loss necessarily imply a direct vascular effect? Not necessarily. Appetite and energy intake change from the first dose; weight loss is continuous, and metabolic and inflammatory changes may begin before a large change appears on the scales. Perhaps Occam’s razor applies: weight loss, beginning almost immediately, may explain more of the benefit than we assume. Then comes the harder question of persistence. Many real-world patients discontinue within a year. If benefits depend on continued pharmacological suppression of appetite, what happens when treatment stops? The biological drive toward weight regain may re-emerge. Rapid weight reduction can also reduce lean body mass along with fat, raising concern about muscle loss and sarcopenia in vulnerable individuals. This does not negate the benefits of weight loss; it reminds us that what is lost may matter as much as how much is lost. There are also questions beyond body composition. Appetite does not operate in isolation; neural pathways regulating food intake intersect with reward and motivation. GLP-1-based therapies are being investigated for effects on alcohol use, nicotine dependence and other reward-driven behaviours. These possibilities may prove therapeutically valuable. But what are the consequences of suppressing these signals for decades? At present, we do not know. That is not an argument against treatment; it is an argument against premature certainty. The deeper issue is not whether these drugs work. They do. It is whether suppressing hunger is the same as correcting the conditions that made us hungry. These drugs can suppress hunger and reduce energy intake; they cannot, by themselves, redesign the food environment, reverse sedentary living, relieve chronic stress or repair disrupted sleep. When treatment stops, pharmacological suppression of appetite stops too, and in many patients the biological drive toward weight regain re-emerges. Thiruvalluvar, writing on medicine some two thousand years before the first GLP-1 molecule, put the matter more economically than any trial report can: “Once digested, eat with moderation; that prolongs the life of one embodied.” — Kural 943 Two thousand years on, we have found a molecule that can pharmacologically quiet the appetite that the Kural asked us to govern ourselves. Whether that counts as an answer—or merely an ingenious way of postponing the same old question—is something the data have not yet settled. Perhaps the real question is not whether we can make ourselves less hungry. It is whether we should be satisfied with treating hunger while leaving the obesogenic world unchanged. Read the full article: Semaglutide and Its Siblings: Are We Trying to Eat the Cake and Have It Too?

    Semaglutide and Its Siblings: Are We Trying to Eat the Cake and Have It Too? Or are we teaching the body to forget hunger while the world that made it hungry stays the same?

  6. Aug 31

    Menarche, Menstruation and Menopause: Are We Mistaking Consequences for Physiology?

    Menarche, Menstruation and Menopause: Are We Mistaking Consequences for Physiology? A woman’s reproductive life is marked by three remarkable events: menarche, menstruation and menopause. We accept them as normal and physiological. But what useful purpose does each event itself serve? Puberty establishes reproductive maturity, yet menarche occurs relatively late, after many physical and endocrine changes have already occurred. Could the first menstrual bleed therefore be regarded as a biomarker of reproductive maturation rather than an independent physiological objective? Menstruation raises a more intriguing question. The endometrium prepares for implantation. But if pregnancy does not occur, why must it be shed? Most mammals do not menstruate. One evolutionary hypothesis proposes that menstruation may not itself have been the trait favoured by natural selection. Spontaneous decidualisation—the preparation of the endometrium for pregnancy before an embryo arrives—may have been adaptive, with menstruation emerging as a consequence when pregnancy does not follow. If so, the reproductive process may be adaptive; the bleeding may simply be its consequence. Menstruation also carries costs. Normal menstrual blood loss represents recurring loss of blood and iron. Some women experience dysmenorrhoea, heavy bleeding, iron deficiency and anaemia, premenstrual symptoms, endometriosis or adenomyosis. These disorders cannot simply be attributed to menstruation, and menstruation is not a disease. Yet normal does not necessarily mean cost-free or beneficial. Our 2014 hypothesis asked whether menstruation should automatically be regarded as a physiological function, or might instead be a sign of failed reproductive function. Menopause presents another evolutionary puzzle. Why should ovarian reproductive capacity cease while a woman may remain alive and functional for decades? The grandmother hypothesis proposes benefits from survival after reproduction, but nature does not intend. Perhaps menopause is, at least partly, a consequence of the finite reproductive lifespan of the ovary—a limitation increasingly visible as human longevity expands. Genetic factors influence both menarche and menopause. Menopause might therefore represent a trade-off of reproductive ageing and longevity rather than a process designed for the woman’s benefit. Could genetic variation and evolution provide a common thread linking all three? Perhaps through the genetic architecture governing reproductive maturation, endometrial biology, ovarian reserve and reproductive ageing. Our hypothesis is cautious: these three events may represent different manifestations of the evolutionary architecture of human reproduction rather than three separate physiological objectives. Menarche may mark reproductive capability; menstruation, an unsuccessful cycle; menopause, the end of ovarian reproductive capability. Perhaps we have been confusing normality with necessity and consequence with purpose. Three events. One reproductive lifespan. Evolution does not guarantee perfection; it favours reproductive success. What is normal may not necessarily be necessary. What is physiological may not necessarily be beneficial. And what evolution has retained may sometimes be a consequence rather than a purpose. Read the full article on Medium: Read the full article

    Menarche, Menstruation and Menopause: Are We Mistaking Consequences for Physiology?

  7. Aug 24

    You, Your Friends, and Your Enemies

    You, Your Friends, and Your Enemies “யாதும் ஊரே; யாவரும் கேளிர்; தீதும் நன்றும் பிறர்தர வாரா.” — கணியன் பூங்குன்றனார், புறநானூறு 192 “Every place is our place; everyone is our kin; evil does not come from others.” Yet there is one person we often overlook: ourselves. You are the most important person in your life. You are your own best friend. You can also be your own worst enemy. The same mind that encourages you can also convince you that you cannot. It can recognise opportunity, but also manufacture excuses and rationalise mistakes. Perhaps the most difficult person to know honestly is oneself. Ancient wisdom tells us: “உன்னை நீ அறிவாயாகில் உனக்கொரு கேடும் இல்லை.” — கைவல்ய நவநீதம் “If you truly understand yourself, there is no harm to yourself.” Self-realisation begins with self-knowledge. Knowing ourselves means recognising our strengths without arrogance and accepting our weaknesses without defeat. It means asking: What are my strengths and weaknesses? What am I afraid of? Which habits help me—and which quietly harm me? Most importantly, where might I be deceiving myself? We are remarkably good at finding others’ faults and surprisingly poor at recognising our own. Ego can turn criticism into insult; fear can masquerade as prudence; stubbornness can disguise itself as conviction. “Keep your friends close and your enemies closer” is a familiar adage. But we should look at it differently. A good friend does not merely agree with us. A true friend sometimes tells us what we do not want to hear. We need such friends. Without such friends, weaknesses can go unrecognised and mistakes can become habits. Thiruvalluvar expressed this centuries ago: “இடிப்பாரை இல்லாத ஏமரா மன்னன் கெடுப்பா ரிலானுங் கெடும்.” — திருக்குறள் 448 The Kural speaks of a king, but its wisdom extends far beyond kingship: people with nobody willing to correct them may eventually be destroyed by their own mistakes. Even an enemy can teach us. Opposition can expose weaknesses, challenge assumptions and force us to examine ideas we might otherwise take for granted. But there is another enemy we should perhaps keep even closer: the enemy within. It may be complacency, ignorance, anger, fear, envy, prejudice or unwillingness to change—the comfortable voice saying, “I am right. I have nothing more to learn.” That voice can sometimes be more dangerous than an external adversary. Yet this is not an argument that everything that happens to us is self-created. Life can bring illness, loss, injustice, betrayal and circumstances we neither choose nor deserve. Others can hurt us, circumstances can overwhelm us, and misfortune can be beyond our control. But our response to what happens—and the meaning we give to it—can often remain within our influence. The most important friendship, therefore, may be our friendship with ourselves. Being our own friend does not mean constantly approving of ourselves. A good friend helps us become better. Be kind to yourself, but be honest with yourself. Celebrate your strengths. Acknowledge your weaknesses. Accept correction. Learn from failure. Change when change is necessary. Before searching for the right friends, understand yourself. Before fearing your enemies, understand yourself. Before judging others, examine yourself. And before trying to change the world around you, have the courage to change what needs changing within you. Keep your friends close. Keep your enemies closer. But keep yourself closest of all.

    You, Your Friends, and Your Enemies

  8. Aug 17

    The Perils of Polypharmacy. What Happens When We Take Too Many Drugs?

    The Perils of Polypharmacy: What Happens When We Take Too Many Drugs? Thiruvalluvar wrote: “மருந்தென வேண்டாவாம் யாக்கைக்கு அருந்தியது அற்றது போற்றி உணின்.” “The body needs no medicine if what has been eaten is properly digested before eating again.” He reminded us that health depends on what enters the body, how much, and with what consequence. Today, we face a different question: what happens when we put too many medicines into the same body? A 2026 global meta-analysis of 545 studies involving more than 16.6 million older adults across 56 countries estimated polypharmacy—commonly defined as five or more medications—at 50.4%. The concern is unexamined polypharmacy: unnecessary medicines and poorly understood combinations. Three blind spots illustrate the problem. 1. The arithmetic of combinations Nine medicines create 36 possible two-drug combinations and 84 possible three-drug combinations. As medication burden rises, evidence supporting the safety of a particular combination becomes thinner. The harder question is what the whole collection does in this patient. 2. The gut we forgot to consult The microbiome interacts with metabolism, immunity and drugs. Human observational studies associate medication burden with microbiome alterations. In aged mice, high-burden polypharmacy altered the gut microbiome, and several changes partially reversed after withdrawal. This is animal evidence—not proof of clinically important microbiome injury in humans. But it raises an important question: could some consequences be reversible, making deprescribing part of recovery? 3. What is on the plate matters too Food–drug interactions are bidirectional. Drugs can alter appetite, gastrointestinal function, absorption and nutritional status, while food can alter drug bioavailability. Polypharmacy has also been associated with malnutrition. Multiple medications are not inherently wrong. Several drugs may be entirely appropriate in complex disease. The question is different: Are we periodically asking whether every medication is still necessary, beneficial and right for the patient—or is it simply being continued because it was prescribed in the past? Deprescribing is deliberate reassessment: Which medication still provides benefit? Which indication has disappeared? Which treatment is redundant? Which drug may now cause more harm than benefit? Which can safely be withdrawn? These questions should be answered with the patient, not for the patient. It is about ensuring that every treatment still has a reason to be there. Thiruvalluvar’s wisdom was not simply about avoiding medicine. It was about knowing what the body receives, respecting proportion, and understanding consequence. Perhaps modern medicine needs to rediscover that principle. We built modern pharmacology one drug at a time. Perhaps we should reconsider what happens when too many drugs enter the same patient. A contemporary Tamil reflection மருந்தை மறுப்பது அறிவன்று; மருந்துகள் பெருகின் மறுபரிசீலிப்பது அறிவு. Wisdom does not lie in rejecting medicine; when medicines multiply, it lies in re-examining them.

    The Perils of Polypharmacy. What Happens When We Take Too Many Drugs?
See All (58)

Ratings & Reviews

5
out of 5
3 Ratings

About

This is is not medical advice. This is food for thought. Please discuss with your doctor before making any change in your food and lifestyle. The escalating global incidence of Type 2 Diabetes Mellitus (T2DM) over the past five decades directly correlates with the parallel rise in overweight and obesity, forming an intertwined epidemic termed "diabesity." This podcast argues that the primary driver of this crisis is the pervasive consumption of "inappropriate food," particularly refined carbohydrates and ultra-processed foods, which disrupt metabolic homeostasis and promote weight gain. We propose that "appropriate food"—defined as whole, fresh, local, plant-based, minimally processed, or unprocessed foods, consumed in appropriate amounts and at appropriate times, and complemented by age-specific exercise—constitutes the fundamental and most effective intervention for T2DM prevention, management, and even remission. This lifestyle-centric approach, supported by emerging insights into the gut microbiome and personalized monitoring via continuous glucose monitors, often renders long-term pharmacotherapy unnecessary and potentially harmful. We critically examine the conventional reliance on chronic drug therapy, highlighting its significant side effects and questionable long-term morbidity/mortality benefits, advocating instead for its judicious use primarily in acute medical emergencies. This podcast calls for a paradigm shift in T2DM management, prioritizing sustainable, food-based lifestyle interventions over a drug-centric model. Disclaimer: This is an opinion podcast for educational purposes only and does not constitute medical advice. Listeners should consult their healthcare providers before making any decisions about diagnosis or treatment.

Information